Literature DB >> 20418694

Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.

Yasuo M Tsutsumi1, Yoshitaka Kawaraguchi, Yousuke T Horikawa, Ingrid R Niesman, Michael W Kidd, Blake Chin-Lee, Brian P Head, Piyush M Patel, David M Roth, Hemal H Patel.   

Abstract

BACKGROUND: Caveolae are small, flask-like invaginations of the plasma membrane. Caveolins are structural proteins found in caveolae that have scaffolding properties to allow organization of signaling. The authors tested the hypothesis that delayed cardiac protection induced by volatile anesthetics is caveolae or caveolin dependent.
METHODS: An in vivo mouse model of ischemia-reperfusion injury with delayed anesthetic preconditioning (APC) was tested in wild-type, caveolin-1 knockout, and caveolin-3 knockout mice. Mice were exposed to 30 min of oxygen or isoflurane and allowed to recover for 24 h. After 24 h recovery, mice underwent 30-min coronary artery occlusion followed by 2 h of reperfusion at which time infarct size was determined. Biochemical assays were also performed in excised hearts.
RESULTS: Infarct size as a percent of the area at risk was reduced by isoflurane in wild-type (24.0 +/- 8.8% vs. 45.1 +/- 10.1%) and caveolin-1 knockout mice (27.2 +/- 12.5%). Caveolin-3 knockout mice did not show delayed APC (41.5 +/- 5.0%). Microscopically distinct caveolae were observed in wild-type and caveolin-1 knockout mice but not in caveolin-3 knockout mice. Delayed APC increased the amount of caveolin-3 protein but not caveolin-1 protein in discontinuous sucrose-gradient buoyant fractions. In addition, glucose transporter-4 was increased in buoyant fractions, and caveolin-3/glucose transporter-4 colocalization was observed in wild-type and caveolin-1 knockout mice after APC.
CONCLUSIONS: These results show that delayed APC involves translocation of caveolin-3 and glucose transporter-4 to caveolae, resulting in delayed protection in the myocardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20418694      PMCID: PMC2860616          DOI: 10.1097/ALN.0b013e3181d3d624

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  54 in total

1.  Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts.

Authors:  Cristina Banfi; Maura Brioschi; Robin Wait; Shajna Begum; Elisabetta Gianazza; Pasquale Fratto; Gianluca Polvani; Ettore Vitali; Alessandro Parolari; Luciana Mussoni; Elena Tremoli
Journal:  Proteomics       Date:  2006-03       Impact factor: 3.984

Review 2.  Inhalational anaesthetics and cardioprotection.

Authors:  N C Weber; W Schlack
Journal:  Handb Exp Pharmacol       Date:  2008

3.  Role of 12-lipoxygenase in volatile anesthetic-induced delayed preconditioning in mice.

Authors:  Yasuo M Tsutsumi; Hemal H Patel; Diane Huang; David M Roth
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-04-28       Impact factor: 4.733

4.  Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway.

Authors:  V O Rybin; X Xu; M P Lisanti; S F Steinberg
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

5.  Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.

Authors:  K Shinmura; X L Tang; Y Wang; Y T Xuan; S Q Liu; H Takano; A Bhatnagar; R Bolli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

6.  Insulin resistance in skeletal muscles of caveolin-3-null mice.

Authors:  Jin Oshikawa; Koji Otsu; Yoshiyuki Toya; Takashi Tsunematsu; Raleigh Hankins; Jun-ichi Kawabe; Susumu Minamisawa; Satoshi Umemura; Yasuko Hagiwara; Yoshihiro Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

7.  Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. Implications for the autonomic regulation of heart rate.

Authors:  O Feron; C Dessy; D J Opel; M A Arstall; R A Kelly; T Michel
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

8.  Reactive oxygen species trigger ischemic and pharmacological postconditioning: in vivo and in vitro characterization.

Authors:  Yasuo M Tsutsumi; Takaakira Yokoyama; Yousuke Horikawa; David M Roth; Hemal H Patel
Journal:  Life Sci       Date:  2007-09-09       Impact factor: 5.037

9.  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Authors:  Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth
Journal:  Circulation       Date:  2008-10-20       Impact factor: 29.690

10.  Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection.

Authors:  Yasuhiro Nishino; Tetsuji Miura; Takayuki Miki; Jun Sakamoto; Yuichi Nakamura; Yoshihiro Ikeda; Hironori Kobayashi; Kazuaki Shimamoto
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

View more
  28 in total

1.  Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.

Authors:  Louise E See Hoe; Jan M Schilling; Emiri Tarbit; Can J Kiessling; Anna R Busija; Ingrid R Niesman; Eugene Du Toit; Kevin J Ashton; David M Roth; John P Headrick; Hemal H Patel; Jason N Peart
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-07-25       Impact factor: 4.733

Review 2.  Caveolins in cardioprotection - translatability and mechanisms.

Authors:  Jan M Schilling; David M Roth; Hemal H Patel
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

3.  Caveolin-3 suppresses late sodium current by inhibiting nNOS-dependent S-nitrosylation of SCN5A.

Authors:  Jianding Cheng; Carmen R Valdivia; Ravi Vaidyanathan; Ravi C Balijepalli; Michael J Ackerman; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2013-03-26       Impact factor: 5.000

4.  Geranylgeranylacetone and volatile anesthetic-induced cardiac protection synergism is dependent on caveolae and caveolin-3.

Authors:  Yasuo M Tsutsumi; Rie Tsutsumi; Yousuke T Horikawa; Yoko Sakai; Eisuke Hamaguchi; Hiroshi Kitahata; Asuka Kasai; Noriko Kambe; Katsuya Tanaka
Journal:  J Anesth       Date:  2014-03-15       Impact factor: 2.078

5.  Caveolae in ventricular myocytes are required for stretch-dependent conduction slowing.

Authors:  E R Pfeiffer; A T Wright; A G Edwards; J C Stowe; K McNall; J Tan; I Niesman; H H Patel; D M Roth; J H Omens; A D McCulloch
Journal:  J Mol Cell Cardiol       Date:  2014-09-26       Impact factor: 5.000

Review 6.  Signaling epicenters: the role of caveolae and caveolins in volatile anesthetic induced cardiac protection.

Authors:  Yousuke T Horikawa; Yasuo M Tsutsumi; Hemal H Patel; David M Roth
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

7.  Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via caveolins.

Authors:  Yoshitaka Kawaraguchi; Yousuke T Horikawa; Anne N Murphy; Fiona Murray; Atsushi Miyanohara; Sameh S Ali; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Anesthesiology       Date:  2011-09       Impact factor: 7.892

8.  Opioid-induced preconditioning is dependent on caveolin-3 expression.

Authors:  Yasuo M Tsutsumi; Yoshitaka Kawaraguchi; Ingrid R Niesman; Hemal H Patel; David M Roth
Journal:  Anesth Analg       Date:  2010-08-24       Impact factor: 5.108

9.  A murine closed-chest model of myocardial ischemia and reperfusion.

Authors:  Se-Chan Kim; Olaf Boehm; Rainer Meyer; Andreas Hoeft; Pascal Knüfermann; Georg Baumgarten
Journal:  J Vis Exp       Date:  2012-07-17       Impact factor: 1.355

10.  The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion.

Authors:  Hong Xie; Xia Liu; Chen Wang; Jiang Zhu; Chen Yang; Chunfeng Liu; Hong Liu; Xuemei Wu
Journal:  Mol Biol Rep       Date:  2013-11-06       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.